Covariate . | β Estimate . | β SE . | P Value . |
---|---|---|---|
HIV status (positive) | 0.21 | 0.07 | 0.01 |
Reproductive aging category | 0.02 | ||
Postmenopausal (Group 3) | Reference | ||
Reduced ovarian reserve (Group 2) | −0.02 | 0.12 | |
Premenopausal (Group 1) | −0.28 | 0.13 | |
Non-HDL-C, mg/dL | 0.001 | 0.002 | 0.60 |
HbA1c, % | 0.29 | 0.23 | 0.23 |
Covariate . | β Estimate . | β SE . | P Value . |
---|---|---|---|
HIV status (positive) | 0.21 | 0.07 | 0.01 |
Reproductive aging category | 0.02 | ||
Postmenopausal (Group 3) | Reference | ||
Reduced ovarian reserve (Group 2) | −0.02 | 0.12 | |
Premenopausal (Group 1) | −0.28 | 0.13 | |
Non-HDL-C, mg/dL | 0.001 | 0.002 | 0.60 |
HbA1c, % | 0.29 | 0.23 | 0.23 |
Overall model R2 = 0.56, P = 0.003. Multivariable modeling was performed using log intramyocardial triglyceride content as the dependent variable. Covariates added to this model included HIV+ status, reproductive aging status, non-HDL-C, and HbA1c. For reproductive aging status, the postmenopausal Group 3 represents the reference group; β estimates are provided for the reduced ovarian reserve Group 2 and the premenopausal Group 1. Reproductive aging status was entered as a nominal variable. For each covariate, the β estimate and β estimate SE are shown. As shown above, HIV+ status and reproductive aging status independently predicted intramyocardial triglyceride content, controlling for non-HDL-C and HbA1c. P values <0.05 are shown in boldface.
Covariate . | β Estimate . | β SE . | P Value . |
---|---|---|---|
HIV status (positive) | 0.21 | 0.07 | 0.01 |
Reproductive aging category | 0.02 | ||
Postmenopausal (Group 3) | Reference | ||
Reduced ovarian reserve (Group 2) | −0.02 | 0.12 | |
Premenopausal (Group 1) | −0.28 | 0.13 | |
Non-HDL-C, mg/dL | 0.001 | 0.002 | 0.60 |
HbA1c, % | 0.29 | 0.23 | 0.23 |
Covariate . | β Estimate . | β SE . | P Value . |
---|---|---|---|
HIV status (positive) | 0.21 | 0.07 | 0.01 |
Reproductive aging category | 0.02 | ||
Postmenopausal (Group 3) | Reference | ||
Reduced ovarian reserve (Group 2) | −0.02 | 0.12 | |
Premenopausal (Group 1) | −0.28 | 0.13 | |
Non-HDL-C, mg/dL | 0.001 | 0.002 | 0.60 |
HbA1c, % | 0.29 | 0.23 | 0.23 |
Overall model R2 = 0.56, P = 0.003. Multivariable modeling was performed using log intramyocardial triglyceride content as the dependent variable. Covariates added to this model included HIV+ status, reproductive aging status, non-HDL-C, and HbA1c. For reproductive aging status, the postmenopausal Group 3 represents the reference group; β estimates are provided for the reduced ovarian reserve Group 2 and the premenopausal Group 1. Reproductive aging status was entered as a nominal variable. For each covariate, the β estimate and β estimate SE are shown. As shown above, HIV+ status and reproductive aging status independently predicted intramyocardial triglyceride content, controlling for non-HDL-C and HbA1c. P values <0.05 are shown in boldface.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.